Black Diamond Therapeutics, Inc.BDTXNASDAQ

Revenue (LTM)

$70M

Net Income (LTM)

$22M

+132.1% YoY

Free Cash Flow

$30M

Revenue CAGR (5Y)

—

—Marginsstable

FCFTurned positive

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	70
Gross Profit	0	0	-0	0	70
Operating Income	-127	-93↑26.8%	-86↑6.9%	-79↑8.9%	20↑125.2%
Net Income	-126	-91↑27.4%	-82↑9.6%	-70↑15.5%	22↑132.1%
EBITDA	-127	-92↑27.1%	-86↑6.8%	-78↑8.8%	20↑125.7%
EPS Diluted	-3.47	-2.52↑27.4%	-1.88↑25.4%	-1.27↑32.4%	0.39↑130.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	66	34↓47.8%	56↑63.8%	36↓35.2%	21↓42.4%
Total Current Assets	216	128↓40.8%	134↑5.0%	101↓24.5%	132↑30.9%
Total Assets	248	156↓36.9%	159↑1.5%	123↓22.7%	143↑16.6%
Total Current Liabilities	24	15↓35.4%	20↑28.7%	21↑4.7%	16↓23.5%
Total Liabilities	52	41↓21.7%	42↑3.1%	39↓5.9%	31↓21.7%
Total Equity	196	116↓40.9%	117↑0.9%	83↓28.7%	112↑34.7%
Total Debt	28	28↓1.1%	25↓10.1%	22↓12.3%	15↓32.1%
Net Debt	-37	-6↑83.5%	-31↓400.8%	-14↑53.9%	-6↑58.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-100	-85↑15.0%	-67↑21.6%	-62↑6.6%	30↑147.5%
Capital Expenditure	-3	-0↑92.9%	-0↑82.8%	0	0
Free Cash Flow	-103	-85↑17.1%	-67↑21.7%	-62↑6.7%	30↑147.5%
Stock-Based Comp	14	12↓13.1%	10↓21.3%	11↑10.7%	7↓37.6%
Net Change in Cash	31	-32↓201.1%	22↑168.4%	-20↓191.8%	-15↑22.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance